One other stock I added was SUWN at .244 Mark on this news: Local Government Designates Veterinary Disinfectants Produced by Sunwin International Neutraceuticals as a Primary Response to Combat the Avian Flu
Wednesday December 7, 8:00 am ET
FORT LAUDERDALE, FL and QUFU, CHINA--(MARKET WIRE)--Dec 7, 2005 -- Sunwin International Neutraceuticals, Inc. (OTC BB:SUWN.OB - News), an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, announces the Jining City Government has designated Sunwin's veterinary disinfectants as a primary response to combat the avian flu virus. Jining City, situated in the southwestern region of the Shandong Province, administers 12 districts, counties and cities including Qufu where Sunwin is headquartered. The Jining City government services a population of 7.56 million within 4,200 square miles. Sunwin is the only provider of veterinary disinfectants in Jining City.
ADVERTISEMENT
Sunwin has developed a series of veterinary disinfectants employing traditional Chinese herbal medicine devised to combat the avian flu virus. The new line of disinfectants has been proven effective in inhibiting the spread of the H5N1 and H9N2 strands of the avian flu. The new series of veterinary disinfectants meets national sanitary standards established by the central government. Recently, Sunwin announced that the department of Livestock and Farming for Shandong Province Government has submitted a fast-track application to the Livestock Farming Bureau of China Ministry of Agriculture on behalf of Sunwin International Neutraceuticals, Inc.
Laiwang Zhang, President and Chairman of Sunwin International Neutraceuticals, Inc., stated, "The central government is mobilizing to prepare for a potential avian flu pandemic. Following the wave of reported cases of avian flu in China, we hope to witness strong demand for our products. Sunwin is committed to providing a solution to combat the avian flu."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. (OTC BB:SUWN.OB - News) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit sunwin.biz
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contact:
Contact:
Christina Hanneman
Tel: 303-220-8476
Fax: 303-773-6492
Email: chrishanneman@mho.com
--------------------------------------------------------------------------------
Source: Sunwin International Neutraceuticals, Inc.
It has a 52wk high of .30 which I'd really like to see taken out but if it can't do it this week I'll get out...tuna |
